44 clinical trials matched your search for Solid Tumors. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Solid Tumors Study of Safety of New Investigational Study Drug Alone and with Nivolumab in Advanced Solid Tumors Mark Stein, MD
Solid Tumors Study of Drug Alone and In Combination with Nivolumab in Advanced Solid Tumors Richard Carvajal, MD
Solid Tumors Study of Drug PLX2853 in Subjects with Advanced Cancer Richard Carvajal, MD
Solid Tumors Study of ASTX029 in Subjects With Advanced Solid Tumors Ryan Moy, MD
Solid Tumors Feasibility, Safety, and Activity Study of BPX-601 in Subjects With Previously Treated Advanced Solid Tumors Mark Stein, MD
Solid Tumors Study of ASTX295 in Patients With Solid Tumors Gary Schwartz, MD
Solid Tumors A Study of XmAb23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) Mark Stein, MD
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Luca Szalontay, MD
Breast Cancer A Study for Patients with Locally Advanced or Metastatic Breast Cancer Using Study Drug GDC-0077 Melissa Accordino, MD
Cancer A Study for Patients with Advanced Solid Tumors Using Study Drug BMS-986207 Shaheer Khan, DO
Pediatric Solid Tumors Study of Selinexor in Pediatric Solid Tumors, including CNS Tumors Luca Szalontay, MD
Cancer Study of Drug (MK-2118) in Patients with Solid Tumors or Lymphomas Matthew Ingham, MD
Cancer Study of COM701 Alone and in Combination with Nivolumain in Patients with Advanced Solid Tumors (Breast Cancer/Ovarian Cancer/Lung Cancer) Benjamin Izar, MD
Cancer Study of IDE196 in Patients with Solid Tumors Richard Carvajal, MD
Cancer Study of Intratumorally Administered INT230-6 in Adult Subjects with Solid Tumors Matthew Ingham, MD
Cancer Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years) Luca Szalontay, MD
Cancer Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (ages 18-21) Luca Szalontay, MD
Cancer Study of LN-145 in the Treatment of Squamous Cell Carcinoma of the Head & Neck or Non Small Cell Lung Cancer (NSCLC) Richard Carvajal, MD
Cancer Study of BA3011 in Subjects with Advanced Solid Tumors Matthew Ingham, MD
Cancer Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Luca Szalontay, MD
Cancer Study of AMG510 in Subjects with Advanced Solid Tumors Catherine Shu, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Richard Carvajal, MD
Cancer Study of ST101 in Patients with Advanced Solid Tumors Fabio Iwamoto, MD
Cancer Study of RTX-240 in Adults with Relapsed/Refractory or Locally Advanced Solid Tumors Mark Stein, MD
Cancer A First-in-Human Study of CDK-002 (exoSTING) in Subjects with Advanced/Metastatic Solid Tumors Matthew Ingham, MD
Cancer A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors Matthew Ingham, MD
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors Richard Carvajal, MD
Cancer COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors Benjamin Izar, MD
Cancer A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors Ryan Moy, MD
Cancer LYT-200 Alone and in Combination With Chemotherapy or Anti-PD-1 in Patients With Metastatic Solid Tumors Gulam Manji, MD, PhD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer First-in-Human Study of DS-7300a in Subjects with Advanced Cancer Mark Stein, MD
Cancer Study of MPT-0118 Alone or in Combination with Keytruda in Patients with Advanced or Metastatic Cancer Shaheer Khan, DO
Cancer Study of INCB106385 Alone or in Combination with INCMGA00012 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of PF-07263689 Alone or in Combination with Sasanlimab for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of RP-6306 in Combination with Gemcitabine (Chemotherapy) for Patients with Advanced Solid Tumors Ryan Moy, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Richard Carvajal, MD
Cancer Study of RP-6306 in Combination with FOLFIRI in Patients with Advanced Solid Tumors (Colon, Esophageal, or GI Cancer) Ryan Moy, MD
Cancer Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors Benjamin Izar, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD